Teni Ernawati

Teni Ernawati

Auto-generated profile, based on publicly available information

Teni Ernawati

Research Center for Pharmaceutical Ingredients and Traditional Medicine National Research and Innovation Agency of Indonesia (BRIN) KST BJ Habibie Kawasan Puspiptek 452 Building Selatan 15314 Tangerang Indonesia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2025 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
BKBetty A Kustiana
Betty A Kustiana
GWGaluh Widiyarti
Galuh Widiyarti
TETeni Ernawati
Teni Ernawati
Cinnamic acid derivatives represent a significant class of biologically active compounds exhibiting a broad spectrum of activities, such as antifungal, antidengue, antimetastatic, antimicrobial, antibacterial, and anticancer properties. Their preparation has attracted considerable attention due to their versatile applications across the pharmaceutical, food, and chemical sectors. This review elucidates the functional groups of cinnamic acid that are instrumental in the rational design of biologically active derivatives. A comprehensive representative of recent advancements in synthetic methodologies over the past five years is presented, particularly emphasizing the active scaffolds of bioactive cinnamic acid derivatives. The review provides a strategic overview of alternative synthetic routes and highlights the latest innovations, including more efficient, highly selective, and environmentally sustainable approaches. Given the widespread incorporation of the cinnamic acid framework in various therapeutic agents, this review delivers critical insights into a molecular design for hit-to-lead optimization, offering detailed synthetic strategies for diverse functional modifications. By critically examining these methodologies, the paper underscores their role in expanding the utility of cinnamic acid derivatives and addressing prevailing challenges.

1 January 2024 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
TETeni Ernawati
Teni Ernawati
NANina Artanti
Nina Artanti
YKYudhi Dwi Kurniawan
Yudhi Dwi Kurniawan
Amide cinnamate and cinnamic acid derivatives are compounds that are potentially useful as anti-cancer agents. The purpose of this study is to assess the anti-cancer properties of seven derivatives of amide cinnamate using both in silico and in vitro methods. The study compared the potential anti-cancer activity of the seven derivatives of amide cinnamate and tamoxifen as a positive control. To evaluate the in silico anti-cancer activity, an α-estrogen receptor was used from the protein data bank (ID: 4 WZV). In addition, the in vitro analysis was conducted on the Michigan Cancer Foundation-7 breast cancer cell line. Out of all the cinnamic amide derivatives examined, phenyl amide cinnamate exhibited the strongest anti-cancer activity. This result was confirmed by molecular docking studies that explored the binding interactions between the amide cinnamate derivatives and cancer proteins. The docking score for phenyl amide cinnamate was the highest, followed by p-methoxy phenyl amide cinnamate and octyl amide cinnamate. However, all the cinnamic amide derivatives tested had lower activity than tamoxifen. The results of the docking studies revealed a significant correlation between the ligand-binding mode and the amino acid residues, as indicated by the in vitro bioactivity tests.

1 December 2024 in Gazi University Journal of Science
Verified
Journal Article
Open access
PDF file
TETeni Ernawati
Teni Ernawati
FHFaris Hermawan
Faris Hermawan
SKSusi Kusumaningrum
Susi Kusumaningrum
Mitragynine is a natural compound found in the leaves of the Mitragyna speciosa tree, commonly known as kratom, which is primarily sourced from Southeast Asia. This review article highlights the methodologies of extraction techniques for isolating mitragynine, purification, characterization, and biosynthesis, including the complete synthesis of mitragynine and its derivatives, and briefly summarizes their biological activities and toxicology of mitragynine. The study was conducted by searching several scientific databases. There were extraction methods for mitragynine, including organic solvent extraction (hexane, chloroform, and methanol), green solvent extraction (distilled water), ultrasound-assisted extraction, and accelerated solvent extraction. The purification process of mitragynine using column chromatography with various eluen, including n-hexane, ethyl acetate, and petroleum ether. The natural mitragynine is mainly generated from the shikimate pathway and monoterpenoid secoiridoid pathway. Furthermore, there were several methods for the complete synthesis of mitragynine and the alteration of its structure. Mitragynine and its derivatives possess various pharmacological properties, including anticancer, Analgesic effects, gastrointestinal effects, antidepressant effects, Impact on cognitive function, antioxidant, and antidiabetic. The higher doses of mitragynine (100 mg/kg) in rats led to changes in hematology and the histopathological examination of the liver and brain indicates signs of toxicity.

1 January 2021 in IOP Conference Series: Materials Science and Engineering
Verified
Conference Paper
Open access
PDF file
TETeni Ernawati
Teni Ernawati
MAMarissa Angelina
Marissa Angelina
RDRizna Triana Dewi
Rizna Triana Dewi
SFSofa Fajriah
Sofa Fajriah
RORokip
Rokip
COVID-19 is a recent coronavirus outbreak caused by SARS-CoV-2 beginning in early December 2019 in Wuhan China raising global health problems. The SARS coronavirus main peptidase (SARS-CoV M(pro)) plays an essential role in the life-cycle of the virus and is a primary target for the development of anti-SARS agents. Also, the viral 3-chymotrypsin-like cysteine protease 3 (3CLpro) enzyme controls coronavirus replication and is essential for its life cycle. Therefore, herein, we performed in silico virtual screening of the compounds fromCassia alataandDendrophthoe petandrasuch as; aloe-emodin, emodin, kaempferol, quercetin and quercitrin against SARS-CoV-2 Mproand also 3CLprothrough molecular docking approach using Autodock 4.2, with the Lamarckian Genetic Algorithm. The binding energies obtained from the result of molecular docking of SARS-CoV-2 Mproand also 3CLproquercetin, kaempferol and aloe-emodin appeared to have the best potential to act as COVID-19 inhibitors.

15 November 2025 in Journal of Multidisciplinary Applied Natural Science
Verified
Journal Article
Open access
HHHusniati Husniati
Husniati Husniati
BEBerna Elya
Berna Elya
MHMuhammad Hanafi
Muhammad Hanafi
AKAlfi Khatib
Alfi Khatib
WAWinni Nur Auli
Winni Nur Auli
RHRizqiya Astri Hapsari
Rizqiya Astri Hapsari
Oxidative stress induced by reactive oxygen species is critical in the progressing of type 2 diabetes mellitus. Thus, early intervention using plant-derived secondary metabolites with antioxidant and α-glucosidase inhibitory (AGI) activities is essential for adequate glycemic control. Pometia pinnata has demonstrated antidiabetic potential, though scientific evidence remains limited. This study aimed to determine the in vitro antioxidant and AGI activities of P. pinnata extracts (fruit peel, root bark, and stem bark). Metabolites from selected stem bark extracts were identified via LC-HRMS and further validated through molecular docking. Sequential maceration using n-hexane, ethyl acetate, methanol, and water was employed to obtain extracts. Ethyl acetate extracts of stem and root bark showed significantly higher total phenolic and flavonoid contents with higher antioxidant activity than other solvent extracts. The stem bark extract yielded the highest compound content (2.74%) and AGI activity (62.78 ± 0.85% inhibition at 15 μg/mL), outperforming the standard drug acarbose (14.66% at the same dose). LC-HRMS profiling of the stem bark extract identified 26 metabolites, with cianidanol exhibiting the strongest binding affinity (ΔG°bind = –7.63 kcal/mol) in molecular docking, surpassing acarbose (–2.51 kcal/mol). These findings confirm the presence of bioactive compounds in P. pinnata that contribute to α-glucosidase inhibition and are correlated with antioxidant capacity.

25 February 2023
Verified
Book Chapter
Open access
PDF file
TETeni Ernawati
Teni Ernawati
In traditional medicine, Z. officinale has been known and used for centuries. However, with the current ongoing COVID-19 pandemic, Z. officinale is increasingly being used to treat symptoms of COVID-19 and increase overall immunity. The presence of multiple phytochemicals contained in Z. officinale has been widely reported. In this study, we tried to observe the inhibitory activity of the chemical constituents in Z. officinale against SAR-CoV-2. We used the main protease COVID-19 receptor which obtained from a protein data bank coded PDB ID 6LU7, to tether the active compound within Z. officinale. Protease is a protein that can represent a target for inhibition of viral replication or transcription. Proteases are widely used in the treatment of viruses since viral replication generally occurs with the aid of proteases. Currently proteases are widely used in the development of antiviral therapy and as a target protein. Evaluation of the inhibitory effect of the active compound in Z. officinale on the protein was performed. The molecular docking results of the 60 chemical compounds contained within Z. officinale showed that there were 2 chemical compounds in Z. officinale, Zingeberene and Lariciresinol that had the highest activity against the protein. Overall, fifteen of the 60 analyze by the molecular docking test showed the ability to inhibit protease protein. The molecular docking simulation showed that Z. officinale has activity against the SARS-CoV-2 PDB 6LU7 protein. The biological activity of potential active compounds in Z. officinale against SARS-CoV-2 and its associated mechanisms of action must be investigated further.